3-ft has been researched along with Experimental Mammary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kodama, M; Kodama, T; Nakamura, Y | 1 |
| Kasahara, N; Kudo, H; Mizuno, M; Mori, T; Nagasawa, H; Sakamoto, S; Sugiura, Y; Suzuki, S | 1 |
2 other study(ies) available for 3-ft and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
The effect of ovariectomy on excretion of urinary steroids and tumor growth in rats bearing 7,12-dimethylbenz[a]anthracene-induced mammary cancer.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adrenal Cortex Hormones; Androgens; Animals; Castration; Cyclophosphamide; Female; Mammary Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Rats; Rats, Inbred Strains; Tegafur | 1982 |
Suppression of mammary tumors by oral administration of 1-(2-tetrahydrofuryl)-5-fluorouracil in combination with uracil in SHN virgin mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Female; Fluorouracil; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Organ Size; Tegafur; Thymidine Kinase; Thymidylate Synthase; Uracil | 1993 |